Obesity and chronic kidney disease;L'obesità corne causa di insuff icienza renale

Recenti Progressi in Medicina

Volumn 101, Issue 2, 2010, Pages 57-60

  Parlongo, Giovanna ^a   Zoccali, Carmine ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Body mass index; Chronic kidney disease; Metabolic syndrome; Obesity; Renal failure; Uremia; Waist hip ratio

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DEATH; DIABETES MELLITUS; DIALYSIS; HUMAN; HYPERTENSION; LIFE EXPECTANCY; METABOLIC SYNDROME X; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; WAIST HIP RATIO; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; FEMALE; INTRAABDOMINAL FAT; MALNUTRITION; MORTALITY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; RENAL REPLACEMENT THERAPY;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY FAILURE, CHRONIC; MALNUTRITION; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RENAL DIALYSIS; RISK FACTORS; WAIST-HIP RATIO;

EID: 77951822129     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: 10.1701/478.5632     Document Type: Review

References (24)

1. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28 (Pubitemid 46780716)
2. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265 (Pubitemid 38037512)
3. ChagnacA, Weinstein T, KorzetsA, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-22.
4. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
5. Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702 (Pubitemid 43794672)
6. Barker DJ, Osmond C, Forsen TJ, et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353: 1802-1809 (Pubitemid 41549892)
7. Brenner BM, Chertow GM. Congenital oligonephropaty and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994; 23:171-175
8. Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001; 37: 720-727 (Pubitemid 32268032)
9. Foster MC, Hwang S-J, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 2008; 52: 39-48. (Pubitemid 351853265)
10. Bello AK, de Zeeuw D, El Nahas M, et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 2007; 22: 1619-1627 (Pubitemid 47073760)
11. SchonerW, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007; 293: C509-C536.
12. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008; 52: 29-38. (Pubitemid 351853273)
13. Zoccali C, Tripepi G, Cambareri F, et al. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr 2005; 15: 125-130 (Pubitemid 40093696)
14. Yusuf S, Hawken S, Ounpuu S, et al, for the INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649
15. Postorino M, Marino C, Tripepi G, Zoccali C; CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272
16. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372 (Pubitemid 37069205)
17. Honda H, Qureshi AR, Axelsson J, et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007; 86: 633-638 (Pubitemid 47435829)
18. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the "beef''? Int J Obes (Lond) 2007; 31: 1552-1553 (Pubitemid 47482662)
19. Romero-Corral A, Montori VM, Somera VK et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368:666-678 (Pubitemid 44223694)
20. Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008; 52: 66-73. (Pubitemid 351853257)
21. De Caterina R, Zoccali C. Therapy in nephrology & hypertension. A companion to Brenner and Rector's The kidney. Third Edition. Philadelphia: Saunders Elsevier 2008: 112-120
22. Axelsson J, Heimburger O, Stenvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 2006; 151: 165-174 (Pubitemid 44298230)
23. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141 (Pubitemid 34042020)
24. Mallamaci F, Tripepi G, Zoccali C. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J Nephrol 2005; 18: 464-468 (Pubitemid 41700115)